Multiplex Biomarker Imaging Market to Reach $523.59 Mn by 2023: Thermo Fisher Scientific, Merck, Illumina, Abcam, Perkin Elmer, US Biomax
The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. According to Netscribes, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018-2023 period, generating a revenue of USD 523.59 Mn by 2023.
View full press release